Northwestern Mutual Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
NIM
FHA
RCM
Northwestern Mutual Wealth Management's HQL Position: Q1 2026 in Review
Northwestern Mutual Wealth Management increased its abrdn Life Sciences Investors (HQL) stake by 6.4% in Q1 2026, buying an estimated $1.14K and bringing the position to 1,123 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2838.
Northwestern Mutual Wealth Management first reported a position in HQL in Q4 2015 and has held it in 13 quarters since. The position peaked at $51K in Q4 2023. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.
- Northwestern Mutual Wealth Management held 1,123 shares of abrdn Life Sciences Investors worth $18.3K as of Q1 2026.
- Northwestern Mutual Wealth Management bought 68 abrdn Life Sciences Investors shares in Q1 2026, an estimated $1.14K.
- abrdn Life Sciences Investors made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2838 holding.
- Northwestern Mutual Wealth Management first reported a position in abrdn Life Sciences Investors in Q4 2015 and has held it in 13 quarters since.
- Northwestern Mutual Wealth Management's abrdn Life Sciences Investors position peaked at $51K in Q4 2023.
- 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.